The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dermatological OTC Drugs Market Research Report 2025
Synopsis
The global Dermatological OTC Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dermatological OTC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological OTC Drugs.
Report Scope
The Dermatological OTC Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological OTC Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological OTC Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perrigo Company plc
Bausch Health Companies Inc.
Dr. Reddy's Laboratories
Johnson and Johnson
Bayer AG
GlaxoSmithKline plc.
Viatris Inc
LEO Pharma A/S
Acella Pharmaceuticals, LLC
Teva Pharmaceutical Industries Ltd.
Galderma
Segment by Type
Acne Medications
Dermatitis Drugs
Fungal Infection Drugs
Segment by Application
Online Distribution
Offline Distribution
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological OTC Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Dermatological OTC Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dermatological OTC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological OTC Drugs.
Report Scope
The Dermatological OTC Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological OTC Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological OTC Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perrigo Company plc
Bausch Health Companies Inc.
Dr. Reddy's Laboratories
Johnson and Johnson
Bayer AG
GlaxoSmithKline plc.
Viatris Inc
LEO Pharma A/S
Acella Pharmaceuticals, LLC
Teva Pharmaceutical Industries Ltd.
Galderma
Segment by Type
Acne Medications
Dermatitis Drugs
Fungal Infection Drugs
Segment by Application
Online Distribution
Offline Distribution
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological OTC Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatological OTC Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Acne Medications
1.2.3 Dermatitis Drugs
1.2.4 Fungal Infection Drugs
1.3 Market by Application
1.3.1 Global Dermatological OTC Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Online Distribution
1.3.3 Offline Distribution
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatological OTC Drugs Market Perspective (2019-2030)
2.2 Dermatological OTC Drugs Growth Trends by Region
2.2.1 Global Dermatological OTC Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dermatological OTC Drugs Historic Market Size by Region (2019-2024)
2.2.3 Dermatological OTC Drugs Forecasted Market Size by Region (2025-2030)
2.3 Dermatological OTC Drugs Market Dynamics
2.3.1 Dermatological OTC Drugs Industry Trends
2.3.2 Dermatological OTC Drugs Market Drivers
2.3.3 Dermatological OTC Drugs Market Challenges
2.3.4 Dermatological OTC Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatological OTC Drugs Players by Revenue
3.1.1 Global Top Dermatological OTC Drugs Players by Revenue (2019-2024)
3.1.2 Global Dermatological OTC Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Dermatological OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatological OTC Drugs Revenue
3.4 Global Dermatological OTC Drugs Market Concentration Ratio
3.4.1 Global Dermatological OTC Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatological OTC Drugs Revenue in 2023
3.5 Dermatological OTC Drugs Key Players Head office and Area Served
3.6 Key Players Dermatological OTC Drugs Product Solution and Service
3.7 Date of Enter into Dermatological OTC Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatological OTC Drugs Breakdown Data by Type
4.1 Global Dermatological OTC Drugs Historic Market Size by Type (2019-2024)
4.2 Global Dermatological OTC Drugs Forecasted Market Size by Type (2025-2030)
5 Dermatological OTC Drugs Breakdown Data by Application
5.1 Global Dermatological OTC Drugs Historic Market Size by Application (2019-2024)
5.2 Global Dermatological OTC Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dermatological OTC Drugs Market Size (2019-2030)
6.2 North America Dermatological OTC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dermatological OTC Drugs Market Size by Country (2019-2024)
6.4 North America Dermatological OTC Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatological OTC Drugs Market Size (2019-2030)
7.2 Europe Dermatological OTC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dermatological OTC Drugs Market Size by Country (2019-2024)
7.4 Europe Dermatological OTC Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatological OTC Drugs Market Size (2019-2030)
8.2 Asia-Pacific Dermatological OTC Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dermatological OTC Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Dermatological OTC Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatological OTC Drugs Market Size (2019-2030)
9.2 Latin America Dermatological OTC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dermatological OTC Drugs Market Size by Country (2019-2024)
9.4 Latin America Dermatological OTC Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatological OTC Drugs Market Size (2019-2030)
10.2 Middle East & Africa Dermatological OTC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dermatological OTC Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Dermatological OTC Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perrigo Company plc
11.1.1 Perrigo Company plc Company Detail
11.1.2 Perrigo Company plc Business Overview
11.1.3 Perrigo Company plc Dermatological OTC Drugs Introduction
11.1.4 Perrigo Company plc Revenue in Dermatological OTC Drugs Business (2019-2024)
11.1.5 Perrigo Company plc Recent Development
11.2 Bausch Health Companies Inc.
11.2.1 Bausch Health Companies Inc. Company Detail
11.2.2 Bausch Health Companies Inc. Business Overview
11.2.3 Bausch Health Companies Inc. Dermatological OTC Drugs Introduction
11.2.4 Bausch Health Companies Inc. Revenue in Dermatological OTC Drugs Business (2019-2024)
11.2.5 Bausch Health Companies Inc. Recent Development
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Detail
11.3.2 Dr. Reddy's Laboratories Business Overview
11.3.3 Dr. Reddy's Laboratories Dermatological OTC Drugs Introduction
11.3.4 Dr. Reddy's Laboratories Revenue in Dermatological OTC Drugs Business (2019-2024)
11.3.5 Dr. Reddy's Laboratories Recent Development
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Detail
11.4.2 Johnson and Johnson Business Overview
11.4.3 Johnson and Johnson Dermatological OTC Drugs Introduction
11.4.4 Johnson and Johnson Revenue in Dermatological OTC Drugs Business (2019-2024)
11.4.5 Johnson and Johnson Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Detail
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Dermatological OTC Drugs Introduction
11.5.4 Bayer AG Revenue in Dermatological OTC Drugs Business (2019-2024)
11.5.5 Bayer AG Recent Development
11.6 GlaxoSmithKline plc.
11.6.1 GlaxoSmithKline plc. Company Detail
11.6.2 GlaxoSmithKline plc. Business Overview
11.6.3 GlaxoSmithKline plc. Dermatological OTC Drugs Introduction
11.6.4 GlaxoSmithKline plc. Revenue in Dermatological OTC Drugs Business (2019-2024)
11.6.5 GlaxoSmithKline plc. Recent Development
11.7 Viatris Inc
11.7.1 Viatris Inc Company Detail
11.7.2 Viatris Inc Business Overview
11.7.3 Viatris Inc Dermatological OTC Drugs Introduction
11.7.4 Viatris Inc Revenue in Dermatological OTC Drugs Business (2019-2024)
11.7.5 Viatris Inc Recent Development
11.8 LEO Pharma A/S
11.8.1 LEO Pharma A/S Company Detail
11.8.2 LEO Pharma A/S Business Overview
11.8.3 LEO Pharma A/S Dermatological OTC Drugs Introduction
11.8.4 LEO Pharma A/S Revenue in Dermatological OTC Drugs Business (2019-2024)
11.8.5 LEO Pharma A/S Recent Development
11.9 Acella Pharmaceuticals, LLC
11.9.1 Acella Pharmaceuticals, LLC Company Detail
11.9.2 Acella Pharmaceuticals, LLC Business Overview
11.9.3 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Introduction
11.9.4 Acella Pharmaceuticals, LLC Revenue in Dermatological OTC Drugs Business (2019-2024)
11.9.5 Acella Pharmaceuticals, LLC Recent Development
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Dermatological OTC Drugs Business (2019-2024)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.11 Galderma
11.11.1 Galderma Company Detail
11.11.2 Galderma Business Overview
11.11.3 Galderma Dermatological OTC Drugs Introduction
11.11.4 Galderma Revenue in Dermatological OTC Drugs Business (2019-2024)
11.11.5 Galderma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Dermatological OTC Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Acne Medications
Table 3. Key Players of Dermatitis Drugs
Table 4. Key Players of Fungal Infection Drugs
Table 5. Global Dermatological OTC Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Dermatological OTC Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Dermatological OTC Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Dermatological OTC Drugs Market Share by Region (2019-2024)
Table 9. Global Dermatological OTC Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Dermatological OTC Drugs Market Share by Region (2025-2030)
Table 11. Dermatological OTC Drugs Market Trends
Table 12. Dermatological OTC Drugs Market Drivers
Table 13. Dermatological OTC Drugs Market Challenges
Table 14. Dermatological OTC Drugs Market Restraints
Table 15. Global Dermatological OTC Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Dermatological OTC Drugs Market Share by Players (2019-2024)
Table 17. Global Top Dermatological OTC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological OTC Drugs as of 2023)
Table 18. Ranking of Global Top Dermatological OTC Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Dermatological OTC Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dermatological OTC Drugs Product Solution and Service
Table 22. Date of Enter into Dermatological OTC Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dermatological OTC Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Dermatological OTC Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Dermatological OTC Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Dermatological OTC Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Dermatological OTC Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Dermatological OTC Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Dermatological OTC Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Dermatological OTC Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Dermatological OTC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Dermatological OTC Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Dermatological OTC Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Dermatological OTC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Dermatological OTC Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Dermatological OTC Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Dermatological OTC Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Dermatological OTC Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Dermatological OTC Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Dermatological OTC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Dermatological OTC Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Dermatological OTC Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Dermatological OTC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Dermatological OTC Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Dermatological OTC Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Perrigo Company plc Company Detail
Table 48. Perrigo Company plc Business Overview
Table 49. Perrigo Company plc Dermatological OTC Drugs Product
Table 50. Perrigo Company plc Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 51. Perrigo Company plc Recent Development
Table 52. Bausch Health Companies Inc. Company Detail
Table 53. Bausch Health Companies Inc. Business Overview
Table 54. Bausch Health Companies Inc. Dermatological OTC Drugs Product
Table 55. Bausch Health Companies Inc. Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 56. Bausch Health Companies Inc. Recent Development
Table 57. Dr. Reddy's Laboratories Company Detail
Table 58. Dr. Reddy's Laboratories Business Overview
Table 59. Dr. Reddy's Laboratories Dermatological OTC Drugs Product
Table 60. Dr. Reddy's Laboratories Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 61. Dr. Reddy's Laboratories Recent Development
Table 62. Johnson and Johnson Company Detail
Table 63. Johnson and Johnson Business Overview
Table 64. Johnson and Johnson Dermatological OTC Drugs Product
Table 65. Johnson and Johnson Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 66. Johnson and Johnson Recent Development
Table 67. Bayer AG Company Detail
Table 68. Bayer AG Business Overview
Table 69. Bayer AG Dermatological OTC Drugs Product
Table 70. Bayer AG Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 71. Bayer AG Recent Development
Table 72. GlaxoSmithKline plc. Company Detail
Table 73. GlaxoSmithKline plc. Business Overview
Table 74. GlaxoSmithKline plc. Dermatological OTC Drugs Product
Table 75. GlaxoSmithKline plc. Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 76. GlaxoSmithKline plc. Recent Development
Table 77. Viatris Inc Company Detail
Table 78. Viatris Inc Business Overview
Table 79. Viatris Inc Dermatological OTC Drugs Product
Table 80. Viatris Inc Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 81. Viatris Inc Recent Development
Table 82. LEO Pharma A/S Company Detail
Table 83. LEO Pharma A/S Business Overview
Table 84. LEO Pharma A/S Dermatological OTC Drugs Product
Table 85. LEO Pharma A/S Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 86. LEO Pharma A/S Recent Development
Table 87. Acella Pharmaceuticals, LLC Company Detail
Table 88. Acella Pharmaceuticals, LLC Business Overview
Table 89. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Product
Table 90. Acella Pharmaceuticals, LLC Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 91. Acella Pharmaceuticals, LLC Recent Development
Table 92. Teva Pharmaceutical Industries Ltd. Company Detail
Table 93. Teva Pharmaceutical Industries Ltd. Business Overview
Table 94. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Product
Table 95. Teva Pharmaceutical Industries Ltd. Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd. Recent Development
Table 97. Galderma Company Detail
Table 98. Galderma Business Overview
Table 99. Galderma Dermatological OTC Drugs Product
Table 100. Galderma Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)
Table 101. Galderma Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatological OTC Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Dermatological OTC Drugs Market Share by Type: 2023 VS 2030
Figure 3. Acne Medications Features
Figure 4. Dermatitis Drugs Features
Figure 5. Fungal Infection Drugs Features
Figure 6. Global Dermatological OTC Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Dermatological OTC Drugs Market Share by Application: 2023 VS 2030
Figure 8. Online Distribution Case Studies
Figure 9. Offline Distribution Case Studies
Figure 10. Dermatological OTC Drugs Report Years Considered
Figure 11. Global Dermatological OTC Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Dermatological OTC Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Dermatological OTC Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Dermatological OTC Drugs Market Share by Players in 2023
Figure 15. Global Top Dermatological OTC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological OTC Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Dermatological OTC Drugs Revenue in 2023
Figure 17. North America Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Dermatological OTC Drugs Market Share by Country (2019-2030)
Figure 19. United States Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Dermatological OTC Drugs Market Share by Country (2019-2030)
Figure 23. Germany Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Dermatological OTC Drugs Market Share by Region (2019-2030)
Figure 31. China Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Dermatological OTC Drugs Market Share by Country (2019-2030)
Figure 39. Mexico Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Dermatological OTC Drugs Market Share by Country (2019-2030)
Figure 43. Turkey Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Perrigo Company plc Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 46. Bausch Health Companies Inc. Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 47. Dr. Reddy's Laboratories Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 48. Johnson and Johnson Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 49. Bayer AG Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 50. GlaxoSmithKline plc. Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 51. Viatris Inc Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 52. LEO Pharma A/S Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 53. Acella Pharmaceuticals, LLC Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 55. Galderma Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
